Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.
暂无分享,去创建一个
[1] G. Bonadonna,et al. The contribution of medicine to the primary treatment of breast cancer. , 1988, Cancer research.
[2] J. Farndon,et al. EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.
[3] C. Redmond,et al. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] P. Gaglia,et al. The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer: a multifactorial analysis. , 1986, European journal of cancer & clinical oncology.
[5] C. Redmond,et al. Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. , 1986, NCI monographs : a publication of the National Cancer Institute.
[6] B. Rasmussen,et al. Steroid hormone receptors as prognostic indicators in primary breast cancer. , 1986, Breast cancer research and treatment.
[7] D. Appleton,et al. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. , 1985, Journal of clinical pathology.
[8] M. Williams,et al. Oestrogen receptors in primary breast cancer. , 1985, British Journal of Cancer.
[9] L. Skoog,et al. DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma. , 1985, Acta radiologica. Oncology.
[10] W. P. Reed,et al. A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer. , 1985, Annals of surgery.
[11] B Fisher,et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.
[12] W D Dupont,et al. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading , 1984, Cancer.
[13] M. Tubiana,et al. The long‐term prognostic significance of the thymidine labelling index in breast cancer , 1984, International journal of cancer.
[14] L. Skoog,et al. Effect of adjuvant therapy in primary breast cancer in relation to the estrogen receptor level. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[15] P. Mullins,et al. Progesterone and estrogen receptors as prognostic variables in breast cancer. , 1983, Cancer research.
[16] M. M. McCrate,et al. Prediction of early course of breast carcinoma by thymidine labeling , 1983, Cancer.
[17] C. Redmond,et al. Pathologic findings from the national surgical adjuvant breast project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation , 1983, Cancer.
[18] H. Sears,et al. Breast cancer without axillary metastases. Are there high‐risk biologic subpopulations? , 1982, Cancer.
[19] W. Recant,et al. Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast , 1982, Journal of surgical oncology.
[20] P. Rosen,et al. Estrogen receptor protein in breast cancer as a predictor of recurrence , 1981, Cancer.
[21] A. Buzdar,et al. Estrogen receptor: A prognostic factor in breast cancer , 1981, Cancer.
[22] K. Griffiths,et al. Possible tests for selection of adjuvant systemic therapy in early cancer of the breast , 1980 .
[23] H. Rockette,et al. Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer , 1980, Cancer.
[24] C. Redmond,et al. Histologic grading of breast cancer. , 1980, Pathology annual.
[25] R. Simon,et al. Association between steroid hormone receptor status and disease-free interval in breast cancer. , 1979, Cancer treatment reports.
[26] R. Hähnel,et al. Prognostic value of estrogen receptors in primary breast cancer , 1979, Cancer.
[27] R. Simon,et al. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. , 1978, The New England journal of medicine.
[28] E. J. Gregory,et al. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. , 1977, Cancer research.
[29] B. Fisher,et al. The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) , 1975, Cancer.
[30] D. Cox. Regression Models and Life-Tables , 1972 .
[31] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[32] F. Ederer,et al. Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.